Published in Front Endocrinol (Lausanne) on May 26, 2014
The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation. EMBO Mol Med (2014) 0.89
Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms. Oncotarget (2015) 0.79
Prolactin Promotes Breast Cancer Cell Migration through Actin Cytoskeleton Remodeling. Front Endocrinol (Lausanne) (2015) 0.77
Estetrol Modulates Endothelial Nitric Oxide Synthesis in Human Endothelial Cells. Front Endocrinol (Lausanne) (2015) 0.75
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling. Front Endocrinol (Lausanne) (2016) 0.75
Investigation of potential molecular biomarkers and small molecule drugs for hepatocellular carcinoma transformed from cirrhosis. Oncol Lett (2016) 0.75
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Cellular motility driven by assembly and disassembly of actin filaments. Cell (2003) 26.05
Reproductive factors and breast cancer. Epidemiol Rev (1993) 8.37
Estrogen carcinogenesis in breast cancer. N Engl J Med (2006) 8.17
Periodic lamellipodial contractions correlate with rearward actin waves. Cell (2004) 6.46
Cortical actin organization: lessons from ERM (ezrin/radixin/moesin) proteins. J Biol Chem (1999) 2.60
Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol (2004) 2.34
Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation. Mol Endocrinol (2002) 2.18
Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures. J Cell Sci (1997) 2.11
Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev (2001) 1.74
Estrogen and progesterone receptors in the normal female breast. Cancer Res (1991) 1.50
Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol (2006) 1.35
Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells. Endocrinology (2005) 1.15
Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP. Mol Endocrinol (2010) 1.12
Rapid signaling of estrogen to WAVE1 and moesin controls neuronal spine formation via the actin cytoskeleton. Mol Endocrinol (2009) 0.95
Fetal and maternal metabolism of estradiol during pregnancy. J Clin Endocrinol Metab (1966) 0.89
Studies on the metabolism of C-19 steroids in the human foeto-placental unit. 4. Aromatisation and hydroxylation products formed by previable foetuses perfused withandrostenedione and testosterone. Acta Endocrinol (Copenh) (1968) 0.87
Estrogen regulates endometrial cell cytoskeletal remodeling and motility via focal adhesion kinase. Fertil Steril (2010) 0.85
Ovulation inhibition by estetrol in an in vivo model. Contraception (2008) 0.84
METABOLISM OF 17-BETA-OESTRADIOL-4-14-C IN EARLY INFANCY. Acta Endocrinol (Copenh) (1965) 0.84
Clinical applications for estetrol. J Steroid Biochem Mol Biol (2009) 0.84
Preventive effect of oral estetrol in a menopausal hot flush model. Climacteric (2008) 0.83
Estetrol review: profile and potential clinical applications. Climacteric (2008) 0.83
Maternal and fetal estetrol levels during pregnancy. Climacteric (2008) 0.83
In vitro effects of estetrol on receptor binding, drug targets and human liver cell metabolism. Climacteric (2008) 0.82
Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model. Climacteric (2008) 0.82
First human exposure to exogenous single-dose oral estetrol in early postmenopausal women. Climacteric (2008) 0.81
Estrogenic uterovaginal effects of oral estetrol in the modified Allen-Doisy test. Climacteric (2008) 0.81
Metabolism of oestrone sulphate by the previable human foetus. Acta Endocrinol (Copenh) (1965) 0.80
STEROID BIOGENESIS AND METABOLISM IN THE HUMAN FOETO-PLACENTAL UNIT AT MIDPREGNANCY. Arch Anat Microsc Morphol Exp (1965) 0.77